{"id":"trazodone-hcl","safety":{"commonSideEffects":[{"rate":"25-50","effect":"Sedation / drowsiness"},{"rate":"10-25","effect":"Dizziness"},{"rate":"10-20","effect":"Dry mouth"},{"rate":"10-15","effect":"Headache"},{"rate":"5-10","effect":"Orthostatic hypotension"},{"rate":"<1","effect":"Priapism (rare)"}]},"_chembl":{"chemblId":"CHEMBL1200798","moleculeType":"Small molecule","molecularWeight":"408.33"},"_dailymed":{"setId":"d52bf663-81d5-431e-a323-ffb72641b3f3","title":"TRAZODONE HCL POWDER [AX PHARMACEUTICAL CORP]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Trazodone inhibits the reuptake of serotonin at the presynaptic membrane, increasing serotonin availability in the synaptic cleft. It also acts as an antagonist at serotonin 5-HT2A receptors, which contributes to its antidepressant and anxiolytic effects. This dual mechanism distinguishes it from selective serotonin reuptake inhibitors (SSRIs) and makes it particularly useful for depression with insomnia due to its sedating properties.","oneSentence":"Trazodone HCl is a serotonin antagonist and reuptake inhibitor (SARI) that blocks serotonin reuptake and antagonizes serotonin 2A receptors to elevate serotonin levels in the brain.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:59:33.150Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Major depressive disorder"},{"name":"Insomnia (off-label use, particularly for sleep maintenance)"}]},"trialDetails":[{"nctId":"NCT03668041","phase":"PHASE3","title":"National Adaptive Trial for PTSD Related Insomnia","status":"ACTIVE_NOT_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2021-02-25","conditions":"Insomnia","enrollment":673},{"nctId":"NCT07136415","phase":"PHASE4","title":"Comparing Digital Therapy, Trazodone, and Daridorexant for Menopause-Related Insomnia Symptoms","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2026-02-13","conditions":"Menopausal Women, Insomnia","enrollment":1000},{"nctId":"NCT07381101","phase":"","title":"Trazodone and the Risk of Serious Adverse Events","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2008-01-01","conditions":"Chronic Kidney Disease (CKD), Older Adults (65 Years and Older)","enrollment":31459},{"nctId":"NCT04302870","phase":"PHASE2, PHASE3","title":"Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial","status":"RECRUITING","sponsor":"University of Edinburgh","startDate":"2020-02-27","conditions":"Motor Neuron Disease, Amyotrophic Lateral Sclerosis","enrollment":1150},{"nctId":"NCT07401836","phase":"NA","title":"Standardized Sleep Bundle for Cardiac Surgery Patients","status":"NOT_YET_RECRUITING","sponsor":"Horizon Health Network","startDate":"2026-03","conditions":"Sleep","enrollment":20},{"nctId":"NCT03511118","phase":"","title":"Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants","status":"RECRUITING","sponsor":"Duke University","startDate":"2018-10-04","conditions":"Lactating Women on Select DOI, Breastfed Infants of Mothers on Select DOI","enrollment":1600},{"nctId":"NCT07377682","phase":"","title":"Real-world Clinical Response to Trazodone in Italy, Poland, and Romania","status":"RECRUITING","sponsor":"Aziende Chimiche Riunite Angelini Francesco S.p.A","startDate":"2025-12-15","conditions":"Depression - Major Depressive Disorder, Cognition Disorders in Old Age","enrollment":120},{"nctId":"NCT07357272","phase":"","title":"A Cohort Study on Increasing Blood Pressure Benefits in Sleep Apnea Patients After CPAP Treatment","status":"RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2025-09-15","conditions":"Hypertension (HTN), Sleep Apnea Syndrome, Obstructive","enrollment":200},{"nctId":"NCT07328373","phase":"","title":"Neurobiological and Genomic Predictors of Relapse in Depression","status":"RECRUITING","sponsor":"Mehmet Kemal Arikan","startDate":"2025-01-01","conditions":"Healthy, Major Depressive Disorder (MDD)","enrollment":204},{"nctId":"NCT07210606","phase":"PHASE4","title":"Central Apnea in Heart Failure: Physiological Mechanisms to Inform Treatment","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-10-01","conditions":"Sleep Disordered Breathing, Able Bodied","enrollment":200},{"nctId":"NCT05209035","phase":"PHASE4","title":"Evaluation of Trazodone in OSA-MCI","status":"ACTIVE_NOT_RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2022-05-10","conditions":"Mild Cognitive Impairment, Obstructive Sleep Apnea","enrollment":134},{"nctId":"NCT06983080","phase":"PHASE2","title":"Efficacy of Trazodone to Treat Insomnia in Older Adults (TRADITION Study)","status":"RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2025-11-10","conditions":"Insomnia Chronic, Older People, Drug Therapy","enrollment":40},{"nctId":"NCT06295562","phase":"PHASE4","title":"Pharmacological Treatment Targeting Endotypic Traits of Obstructive Sleep Apnea","status":"COMPLETED","sponsor":"China Medical University Hospital","startDate":"2024-11-05","conditions":"Obstructive Sleep Apnea of Adult","enrollment":45},{"nctId":"NCT02922894","phase":"PHASE4","title":"Treatment of Sleep Apnea in Patients With Cervical Spinal Cord Injury","status":"RECRUITING","sponsor":"John D. Dingell VA Medical Center","startDate":"2017-06-09","conditions":"Sleep Apnea, Spinal Cord Injury","enrollment":100},{"nctId":"NCT06281756","phase":"EARLY_PHASE1","title":"Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia","status":"RECRUITING","sponsor":"Milton S. Hershey Medical Center","startDate":"2024-03-20","conditions":"Insomnia, Insomnia Chronic, Insomnia, Primary","enrollment":600},{"nctId":"NCT07210112","phase":"PHASE2","title":"Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier St Anne","startDate":"2025-10-08","conditions":"Depression - Major Depressive Disorder, Treatment-resistant Depression (TRD)","enrollment":112},{"nctId":"NCT05282550","phase":"PHASE2","title":"Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2023-02-02","conditions":"AMCI - Amnestic Mild Cognitive Impairment, Sleep Disturbance","enrollment":100},{"nctId":"NCT06591091","phase":"PHASE2","title":"Clemastine for Improving White Matter and Boosting Antidepressant Response in Late-life Depression","status":"NOT_YET_RECRUITING","sponsor":"University of Illinois at Chicago","startDate":"2025-09","conditions":"Depression","enrollment":80},{"nctId":"NCT06773767","phase":"PHASE1","title":"Bioavailability of Trazodone Hydrochloride (New Polymer) vs. Trazodone Hydrochloride Contramid® at Steady-state.","status":"COMPLETED","sponsor":"Aziende Chimiche Riunite Angelini Francesco S.p.A","startDate":"2024-05-22","conditions":"Bioavailability Heathy Volunteers, Bioavailability Study, Bioequivalance","enrollment":64},{"nctId":"NCT06517797","phase":"PHASE2","title":"One-Year Study of S1B-509 vs Placebo for Weight Loss","status":"NOT_YET_RECRUITING","sponsor":"S1 Biopharma, Inc.","startDate":"2025-10-15","conditions":"Obesity","enrollment":210},{"nctId":"NCT03852160","phase":"PHASE3","title":"A Study of Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus a New Standard-of-care Oral Antidepressant in Adult and Elderly Participants With Treatment-resistant Depression","status":"WITHDRAWN","sponsor":"Janssen-Cilag International NV","startDate":"2019-12-01","conditions":"Depressive Disorder, Treatment-Resistant","enrollment":""},{"nctId":"NCT05299398","phase":"PHASE1","title":"Prevention of Postpartum Depression: A Pilot Placebo-controlled Trial of Trazodone","status":"WITHDRAWN","sponsor":"Verinder Sharma","startDate":"2025-04-17","conditions":"Postpartum Depression","enrollment":""},{"nctId":"NCT04468776","phase":"PHASE4","title":"CBT-I or Zolpidem/Trazodone for Insomnia","status":"COMPLETED","sponsor":"California Pacific Medical Center Research Institute","startDate":"2022-02-25","conditions":"Chronic Insomnia","enrollment":155},{"nctId":"NCT06740188","phase":"PHASE4","title":"Trazodone on NREM Sleep Stage Ⅲ in Depressed Insomniac Co-morbid Patients","status":"RECRUITING","sponsor":"Tongji University","startDate":"2025-01-01","conditions":"Depressed Insomniac Co-morbid Patients","enrollment":60},{"nctId":"NCT06286189","phase":"PHASE1, PHASE2","title":"Trazodone on OSA Endotypes","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2024-01-01","conditions":"Obstructive Sleep Apnea","enrollment":18},{"nctId":"NCT05125146","phase":"NA","title":"Investigating the Effectiveness of E-CBTi Compared to Pharmaceutical Interventions in Treating Insomnia","status":"RECRUITING","sponsor":"Dr. Nazanin Alavi","startDate":"2021-11-01","conditions":"Insomnia","enrollment":60},{"nctId":"NCT06546358","phase":"EARLY_PHASE1","title":"Quetiapine Versus Trazadone in Women With Postpartum Depression","status":"NOT_YET_RECRUITING","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2024-09","conditions":"Postpartum Depression","enrollment":50},{"nctId":"NCT05293600","phase":"PHASE1, PHASE2","title":"Rescue Pharmacotherapy for OSA","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2023-07-01","conditions":"Obstructive Sleep Apnea","enrollment":70},{"nctId":"NCT05307003","phase":"","title":"Trazodone vs. Quetiapine for the Treatment of ICU Delirium","status":"RECRUITING","sponsor":"University of Southern California","startDate":"2023-04-01","conditions":"Delirium, Delirium of Mixed Origin, Delirium, Sepsis Associated","enrollment":60},{"nctId":"NCT05085808","phase":"PHASE4","title":"RCT: Trazodone vs Quetiapine vs Placebo for Treating ICU Delirium (TraQ)","status":"NOT_YET_RECRUITING","sponsor":"University of Southern California","startDate":"2025-03-01","conditions":"Delirium, Morality, Quality of Life","enrollment":30},{"nctId":"NCT03534284","phase":"PHASE3","title":"Short and Long-Term Effectiveness of Existing Insomnia Therapies for Patients Undergoing Hemodialysis","status":"COMPLETED","sponsor":"University of Washington","startDate":"2018-09-19","conditions":"Insomnia, End Stage Renal Disease","enrollment":126},{"nctId":"NCT05889234","phase":"","title":"Multimodal Magnetic Resonance Imaging-based Study of Electroconvulsive Efficacy Prediction in Adolescents With Depression: a Multicenter Prospective Cohort Study","status":"UNKNOWN","sponsor":"First Affiliated Hospital of Chongqing Medical University","startDate":"2023-11-06","conditions":"Major Depressive Disorder, Magnetic Resonance Imaging, Electroconvulsive Therapy","enrollment":180},{"nctId":"NCT05931965","phase":"NA","title":"Combination Therapy of Different Antidepressants With Dietary Supplements","status":"COMPLETED","sponsor":"Riphah International University","startDate":"2022-10-05","conditions":"Depression","enrollment":88},{"nctId":"NCT04280965","phase":"EARLY_PHASE1","title":"Quetiapine Augmentation of PE Therapy for the Treatment of Co-occurring PTSD and Mild Traumatic Brain Injury","status":"COMPLETED","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2019-02-01","conditions":"Post Traumatic Stress Disorder","enrollment":28},{"nctId":"NCT04295941","phase":"","title":"Long-term Study With Trazodone Once-a-Day","status":"COMPLETED","sponsor":"Aziende Chimiche Riunite Angelini Francesco S.p.A","startDate":"2020-06-23","conditions":"Major Depressive Disorder","enrollment":200},{"nctId":"NCT04082806","phase":"PHASE2","title":"Memory Enhancement by Gamma-hydroxybutyrate vs. Trazodone in Major Depressive Disorder.","status":"COMPLETED","sponsor":"Erich Seifritz","startDate":"2020-08-06","conditions":"Major Depressive Disorder","enrollment":54},{"nctId":"NCT05136521","phase":"PHASE1","title":"Bioavailability Study of 300 mg Trazodone Hydrochloride (New Polymer) vs. 300 mg Trazodone Hydrochloride (Contramid® Prolonged-release Tablets) Under Fasting Conditions","status":"COMPLETED","sponsor":"Aziende Chimiche Riunite Angelini Francesco S.p.A","startDate":"2020-02-17","conditions":"Healthy","enrollment":28},{"nctId":"NCT02655354","phase":"NA","title":"A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity","status":"COMPLETED","sponsor":"University of Washington","startDate":"2015-10","conditions":"Posttraumatic Stress Disorder, Depression, Alcohol-Related Disorders","enrollment":635},{"nctId":"NCT01030874","phase":"NA","title":"Orthostatic Hypotension Treatment on Rehab Unit","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2011-10","conditions":"Orthostatic Hypotension, Falls","enrollment":356},{"nctId":"NCT02458469","phase":"PHASE2","title":"Role of Enhancing Serotonin Receptors Activity for Sleep Apnea Treatment in Patients With SCI","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2015-05-14","conditions":"Spinal Cord Injury, Sleep Disordered Breathing","enrollment":15},{"nctId":"NCT03749642","phase":"PHASE2","title":"Trazodone/Gabapentin Fixed Dose Combination Products in Painful Diabetic Neuropathy","status":"COMPLETED","sponsor":"Aziende Chimiche Riunite Angelini Francesco S.p.A","startDate":"2018-11-22","conditions":"Painful Diabetic Neuropathy","enrollment":240},{"nctId":"NCT01651442","phase":"NA","title":"Sequenced Therapies for Comorbid and Primary Insomnias","status":"COMPLETED","sponsor":"Jack Edinger, PhD","startDate":"2012-08-01","conditions":"Insomnia Comorbid to Psychiatric Disorder, Primary Insomnia","enrollment":211},{"nctId":"NCT01347541","phase":"PHASE1","title":"Piloting Acute Care to Primary Care Linkage of Safety Net Patients","status":"TERMINATED","sponsor":"University of Washington","startDate":"2011-01","conditions":"Posttraumatic Stress Disorder","enrollment":4},{"nctId":"NCT00270959","phase":"PHASE1","title":"Patient-Centered Collaborative Care for Preventing Post-Traumatic Stress Disorder After Traumatic Injury","status":"COMPLETED","sponsor":"University of Washington","startDate":"2006-06","conditions":"Post-Traumatic Stress Disorder","enrollment":207},{"nctId":"NCT03516630","phase":"PHASE1","title":"Effects of Three Single Oral Doses of Trazodone on the QTc Interval Duration in Healthy Volunteers","status":"COMPLETED","sponsor":"Aziende Chimiche Riunite Angelini Francesco S.p.A","startDate":"2017-03-20","conditions":"Healthy","enrollment":20},{"nctId":"NCT02945644","phase":"PHASE1","title":"Trazodone Dose Tolerance and APAP Adherence","status":"SUSPENDED","sponsor":"Louis Stokes VA Medical Center","startDate":"2017-02-13","conditions":"Sleep Apnea, Obstructive","enrollment":45},{"nctId":"NCT04162743","phase":"PHASE4","title":"The Effect of Trazodone on the Severity of Obstructive Sleep Apnea in Insomnic Stroke Patients With Depression","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2019-02-01","conditions":"Sleep Apnea Syndromes, Cerebral Infarction","enrollment":22},{"nctId":"NCT01348542","phase":"NA","title":"Study of Trazodone & Cognitive Behavioral Therapy to Treat Insomnia","status":"COMPLETED","sponsor":"Milton S. Hershey Medical Center","startDate":"2011-04","conditions":"Insomnia","enrollment":24},{"nctId":"NCT03522207","phase":"PHASE4","title":"Accuracy and Efficacy of Trazodone (Desyrel) on Sleep Quality and Pain Management of TMD Patient","status":"TERMINATED","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2018-10-15","conditions":"TMD, Sleep Bruxism, TMJ Pain","enrollment":3},{"nctId":"NCT02118688","phase":"PHASE4","title":"Efficacy and Safety of Risperidone and Trazodone Monotherapy and Combination Therapy in Critically Ill Patients With Delirium","status":"WITHDRAWN","sponsor":"Rochester General Hospital","startDate":"2011-03","conditions":"Delirium, Agitation","enrollment":""},{"nctId":"NCT02699138","phase":"EARLY_PHASE1","title":"Obstructive Sleep Apnea and Arousal Threshold in Patients With Post-traumatic Stress Disorder","status":"WITHDRAWN","sponsor":"University of California, San Diego","startDate":"2021-10","conditions":"Sleep Apnea, Obstructive; Post-Traumatic Stress Disorders","enrollment":""},{"nctId":"NCT01662297","phase":"PHASE4","title":"Comparison of Quetiapine and Trazodone Treatment for Insomnia in Dually Diagnosed Veterans","status":"TERMINATED","sponsor":"VA Connecticut Healthcare System","startDate":"2012-07","conditions":"Insomnia, Mental Health Disorder, Substance Use Disorder","enrollment":1},{"nctId":"NCT03202979","phase":"PHASE2","title":"Trazodone in Painful Diabetic Neuropathy","status":"COMPLETED","sponsor":"Aziende Chimiche Riunite Angelini Francesco S.p.A","startDate":"2017-05-16","conditions":"Painful Diabetic Neuropathy","enrollment":142},{"nctId":"NCT02785614","phase":"PHASE1","title":"PK Study of Multi-dose Trazodone Hydrochloride Prolonged-released Tablets in Healthy Chinese","status":"COMPLETED","sponsor":"Lee's Pharmaceutical Limited","startDate":"2017-05-01","conditions":"Depression","enrollment":12},{"nctId":"NCT02785601","phase":"PHASE1","title":"PK Study of Diet Effect of Trazodone Hydrochloride Prolonged-Released Tablets in Healthy Chinese","status":"COMPLETED","sponsor":"Lee's Pharmaceutical Limited","startDate":"2017-05-01","conditions":"Depression","enrollment":15},{"nctId":"NCT01943435","phase":"NA","title":"Study Comparing 3 Different Treatments for Arthritis of the Lower Back (Lumbar Spinal Stenosis)","status":"COMPLETED","sponsor":"Michael Schneider, DC, PhD","startDate":"2013-11-20","conditions":"Lumbar Spinal Stenosis","enrollment":259},{"nctId":"NCT02374567","phase":"PHASE3","title":"Pharmacovigilance in Gerontopsychiatric Patients","status":"TERMINATED","sponsor":"Hannover Medical School","startDate":"2015-01","conditions":"Dementia, Depression, Schizophrenia","enrollment":407},{"nctId":"NCT01817907","phase":"NA","title":"The Effects of Trazodone on Sleep Apnea Severity","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2013-03","conditions":"Sleep Apnea, Obstructive","enrollment":15},{"nctId":"NCT02873234","phase":"","title":"A Study of Chinese Medicine Treating Depression","status":"UNKNOWN","sponsor":"The Third Affiliated Hospital of Beijing University of Chinese Medicine","startDate":"2016-06","conditions":"Depression","enrollment":4600},{"nctId":"NCT00817011","phase":"NA","title":"Development of Pharmacogenomic Method to Predict Antidepressant Responsiveness","status":"UNKNOWN","sponsor":"Samsung Medical Center","startDate":"2006-04","conditions":"Depression, Antidepressant Drug Adverse Reaction","enrollment":1000},{"nctId":"NCT02086929","phase":"PHASE3","title":"Trazodone Once a Day in Major Depression Disorder","status":"COMPLETED","sponsor":"Aziende Chimiche Riunite Angelini Francesco S.p.A","startDate":"2012-12","conditions":"Major Depressive Disorder","enrollment":364},{"nctId":"NCT00791739","phase":"PHASE4","title":"Trazodone and Its Augmentation With Pregabalin in the Treatment of Fibromyalgia","status":"COMPLETED","sponsor":"Universidad de Granada","startDate":"2008-04","conditions":"Fibromyalgia","enrollment":66},{"nctId":"NCT01857596","phase":"PHASE1, PHASE2","title":"Phase 1b/2a Unblinded Study of Responses in Premenopausal Women With HSDD to Lorexys Evaluating Efficacy and Safety","status":"COMPLETED","sponsor":"S1 Biopharma, Inc.","startDate":"2013-04","conditions":"Hypoactive Sexual Desire Disorder (DSM-IV-TR Defined), Sexual Interest/Arousal Disorder (DSM-5 Defined)","enrollment":30},{"nctId":"NCT01524497","phase":"PHASE2, PHASE3","title":"A Clinical Study of Trazodone Hydrochloride Prolonged-Release Tablets for Treatment of Depression","status":"COMPLETED","sponsor":"Lee's Pharmaceutical Limited","startDate":"2011-11","conditions":"Depression","enrollment":382},{"nctId":"NCT00253890","phase":"PHASE3","title":"Insomnia and Drug Relapse Risk","status":"COMPLETED","sponsor":"Butler Hospital","startDate":"2005-10","conditions":"Poor Quality Sleep, Opiate Addiction","enrollment":137},{"nctId":"NCT01896349","phase":"NA","title":"Interpersonal Psychotherapy for Treatment Resistant Depression","status":"UNKNOWN","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2013-04","conditions":"Treatment Resistant Depression","enrollment":74},{"nctId":"NCT01764867","phase":"PHASE4","title":"Algorithm Guided Treatment Strategies for Major Depressive Disorder","status":"UNKNOWN","sponsor":"Shanghai Mental Health Center","startDate":"2012-06","conditions":"Major Depressive Disorder","enrollment":1080},{"nctId":"NCT01142258","phase":"PHASE3","title":"Trazodone for Sleep Disorders in Alzheimer's Disease","status":"COMPLETED","sponsor":"Brasilia University Hospital","startDate":"2010-03","conditions":"Sleep, Sleep Disorders, Insomnia","enrollment":40},{"nctId":"NCT01121926","phase":"PHASE1","title":"A Study to Compare the Bioavailability of 300 mg Trazodone Hydrochloride Extended-release Caplets and 100 mg Trazodone Hydrochloride Immediate-release Tablets at Steady State","status":"COMPLETED","sponsor":"Labopharm Inc.","startDate":"2008-01","conditions":"Healthy Subjects, Bioavailability, Pharmacokinetics","enrollment":30},{"nctId":"NCT00839072","phase":"PHASE1","title":"Comparative Bioavailability Study of Extended-release and Immediate-release Trazodone in Healthy Adult Volunteers","status":"COMPLETED","sponsor":"Labopharm Inc.","startDate":"2009-02","conditions":"Healthy","enrollment":24},{"nctId":"NCT01121900","phase":"PHASE1","title":"A Study to Compare the Bioavailability of 300 mg Trazodone Hydrochloride Extended-release Caplets and 100 mg Trazodone Hydrochloride Immediate-release Tablets (Administered Three Times Daily)","status":"COMPLETED","sponsor":"Labopharm Inc.","startDate":"2008-06","conditions":"Healthy","enrollment":26},{"nctId":"NCT00775203","phase":"PHASE3","title":"A Randomized, Double-blind, Two-arm Study Comparing the Efficacy and Safety of Trazodone Contramid® OAD and Placebo in the Treatment of Unipolar Major Depressive Disorder.","status":"COMPLETED","sponsor":"Labopharm Inc.","startDate":"2007-06","conditions":"Major Depressive Disorder","enrollment":412},{"nctId":"NCT01121913","phase":"PHASE1","title":"Comparative Bioavailability Study of Two Prototypes of Trazodone Controlled-release Products and Two Marketed Reference Products in Healthy Volunteers","status":"COMPLETED","sponsor":"Labopharm Inc.","startDate":"2005-03","conditions":"Healthy","enrollment":24},{"nctId":"NCT01097980","phase":"NA","title":"Trazodone for SSRI-sexual Dsyfunction","status":"COMPLETED","sponsor":"Beitou Armed Forces Hospital, Taipei, Taiwan","startDate":"2010-04","conditions":"Sexual Dysfunction","enrollment":56},{"nctId":"NCT00707915","phase":"PHASE4","title":"Effects of Discontinuation of Benzodiazepine-derivative Hypnotics on Cognitive and Motor Functions in Elderly Persons","status":"COMPLETED","sponsor":"Minamihanno Hospital","startDate":"2008-01","conditions":"Adverse Effects","enrollment":30},{"nctId":"NCT01468038","phase":"PHASE3","title":"A Double-blind Placebo Controlled Trial of Sentra PM, a Medical Food","status":"COMPLETED","sponsor":"Targeted Medical Pharma","startDate":"2008-04","conditions":"Sleep Disorder","enrollment":111},{"nctId":"NCT01400165","phase":"PHASE1","title":"Comparison of the Pharmacokinetics of Three Generic Medications and Their Respective Brand Preparations","status":"UNKNOWN","sponsor":"University of Ottawa","startDate":"2011-07","conditions":"Healthy","enrollment":30},{"nctId":"NCT00704860","phase":"PHASE4","title":"Treatment-Resistant Depression, Hippocampus Atrophy and Serotonin Genetic Polymorphism","status":"COMPLETED","sponsor":"University of Ottawa","startDate":"2005-02","conditions":"Major Depression","enrollment":27},{"nctId":"NCT00027053","phase":"PHASE2","title":"Trazodone for Sleep Disturbance in Early Alcohol Recovery","status":"COMPLETED","sponsor":"Rhode Island Hospital","startDate":"2002-06","conditions":"Alcoholism","enrollment":173},{"nctId":"NCT00659919","phase":"PHASE4","title":"Treatment of Neuroleptic Induced Acute Akathisia With Trazodone","status":"COMPLETED","sponsor":"BeerYaakov Mental Health Center","startDate":"2000-11","conditions":"Schizophrenia","enrollment":13},{"nctId":"NCT00000179","phase":"PHASE3","title":"Agitation in Alzheimer's Disease","status":"COMPLETED","sponsor":"National Institute on Aging (NIA)","startDate":"","conditions":"Alzheimer Disease","enrollment":""}],"_emaApprovals":[],"_faersSignals":[{"count":1427,"reaction":"NAUSEA"},{"count":1360,"reaction":"FATIGUE"},{"count":1248,"reaction":"HEADACHE"},{"count":1137,"reaction":"PAIN"},{"count":1085,"reaction":"DRUG INEFFECTIVE"},{"count":1041,"reaction":"DYSPNOEA"},{"count":962,"reaction":"DIARRHOEA"},{"count":950,"reaction":"DIZZINESS"},{"count":925,"reaction":"DEPRESSION"},{"count":896,"reaction":"INSOMNIA"}],"_approvalHistory":[],"publicationCount":14,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Oleptro"],"phase":"marketed","status":"active","brandName":"Trazodone HCl","genericName":"Trazodone HCl","companyName":"Labopharm Inc.","companyId":"labopharm-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Trazodone HCl is a serotonin antagonist and reuptake inhibitor (SARI) that blocks serotonin reuptake and antagonizes serotonin 2A receptors to elevate serotonin levels in the brain. Used for Major depressive disorder, Insomnia (off-label use, particularly for sleep maintenance).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}